Navigation Links
Ginger Eases Nausea From Chemo
Date:5/14/2009

Spice produced 40% reduction in symptoms among breast cancer patients

THURSDAY, May 14 (HealthDay News) -- Researchers have discovered the nausea-easing powers of ginger that many grandmothers are already familiar with, and report that the spice helped cancer patients who were undergoing chemotherapy.

"Ginger at a daily dose of 0.5-to-1 gram significantly aids in the reduction of chemotherapy-related nausea on the first day of chemotherapy, and reduced nausea will lead to improved quality of life in many cancer patients," said study author Julie Ryan, an assistant professor of dermatology and radiation oncology at the James P. Wilmot Cancer Center at the University of Rochester, said during a Thursday teleconference highlighting research that will be presented later this month during the American Society of Clinical Oncology (ASCO) annual meeting in Florida.

That dose is the equivalent of 1/4 to 1/2 a teaspoon of ground ginger, she added.

The trial participants, mostly women and mostly breast cancer patients, were also taking conventional drugs to quell vomiting.

"A lot of patients ask us as oncologists, 'Is there anything more I can do to deal with chemotherapy-induced nausea?' " said Dr. Douglas Blayney, president-elect of ASCO and medical director of the Comprehensive Cancer Center at the University of Michigan, in Ann Arbor.

The majority of patients undergoing chemotherapy do have nausea and vomiting. And nausea can persist even if actual vomiting is stopped. Some 70 percent of patients in chemo still have the symptoms even with common use of antiemetic, or anti-vomiting, drugs.

Ginger is a spice that has been widely used for decades to treat nausea and vomiting, Ryan stated.

These researchers, supported by the U.S. National Cancer Institute, enrolled 644 cancer patients who had already experienced nausea after chemotherapy. All participants had to still be facing at least three rounds of chemo.

The trial is the largest of its kind, according to the researchers.

Participants were randomized to receive either a placebo or one of three doses of ginger supplement: 0.5 grams, 1 gram or 1.5 grams for three days before the start of chemo and three days after for the next two cycles. All also received traditional antiemetic drugs on the first day of treatment.

Most patients report the most severe nausea and vomiting on the first day of chemo, Ryan said. If nausea can be reduced during this critical time period, subsequent nausea is also less likely.

While all doses of ginger helped with nausea, "The largest reduction in nausea occurred with 0.5 and 1 gram of ginger, which was about a 40 percent reduction in nausea," Ryan reported. The effect tended to wear off over the next 24 hours.

It wasn't clear if the same effects would be seen with ginger products, such as tea, ginger cookies and sushi, the researchers said.

More information

The U.S. National Cancer Institute has more on the side effects of chemotherapy.



SOURCES: May 14, 2009, teleconference with Julie Ryan, Ph.D., assistant professor, dermatology and radiation oncology, University of Rochester, and Douglas Blayney, M.D., president-elect, American Society of Clinical Oncology, and medical director, Comprehensive Cancer Center, University of Michigan, Ann Arbor


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Ginger Zee, Recipient of Community Service Award
2. Oh Mama! Heads Back to the Lab to Create the First Ever Ginger-Ale for Moms-To-Be
3. ASN increases knowledge of geriatric kidney disease
4. Reducing Chronic Diseases Critical to Economic Recovery and Health Reform
5. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
6. Combo Treatment Eases Wheezing in Babies
7. MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009
8. Stanford Center on Longevity Releases New Findings About Voter Attitudes on Health Care Reform
9. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
10. KLRI Releases 3rd Annual Report On Years Top Longevity Research Findings
11. Ericoms Remote Access and Business Continuity Solution Increases Immunity to Productivity Losses -- Combats Swine Flu Scare
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ginger Eases Nausea From Chemo
(Date:3/24/2017)... ... , ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce the ... clinic is the group’s 7th location in San Antonio and 23rd in Texas. ... care from the clinic, which opened March 22, 2017. , The team ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... financial planning, and related services to families and business owners across eastern Michigan, ... at feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food ...
(Date:3/24/2017)... Diego, Calif. (PRWEB) , ... March 24, 2017 ... ... has raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... the instant demand for the product – with nearly 2,000 consumers (and counting) ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... Assili, announce that they are now offering treatments for sleep apnea and TMJ ... dental offices. Sleep apnea , specifically the obstructive type, is increasingly being ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of ... N.Y., is pleased to announce Westchester resident Lauren C. Enea has joined the firm ... the firm, will concentrate her practice in elder law, Medicaid planning and applications, and ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 2017 Today Stock-Callers.com have issued research ... Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences ... SSH ). These companies are part of the Healthcare sector, ... March 23 rd , 2017, with the NYSE Health Care ... care companies in the S&P 500 were down about 0.4% ...
(Date:3/24/2017)... INDIANAPOLIS , March 24, 2017  Eli ... today announced plans to invest $850 million in ... span facilities across its U.S. enterprise, including research ... The investments are being driven by demand for ... of potential medicines in development targeting cancer, pain, ...
(Date:3/24/2017)... March 23, 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: ... a clinical-stage oncology and dermatology biopharmaceutical company, today ... Commitment Term Sheet (the "Definitive Financing") it entered ... the Company,s stockholders, who are referred to in ... Form 8-K filed with the Securities and Exchange ...
Breaking Medicine Technology: